Amgen (AMGN) stock-based compensation was $494M in FY2025 (-7% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$494M
-7%
2024
$530M
+12%
2023
$473M
+18%
2022
$401M
+18%
2021
$341M
+3%
2020
$330M
+7%
2019
$308M
-1%
2018
$311M
-5%
2017
$329M
+6%
2016
$311M
-3%
2015
$322M
-21%
2014
$408M
+1%
2013
$403M
+11%
2012
$362M
+6%
2011
$341M
-3%
2010
$353M
+24%
2009
$284M
+8%
2008
$262M
-0%
2007
$263M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q1 2026
$75M
Q4 2025
$125M
Q3 2025
$127M
Q2 2025
$157M
Q1 2025
$85M
Q4 2024
$134M
Q3 2024
$136M
Q2 2024
$157M
Q1 2024
$103M
Q4 2023
$203M
Q3 2023
$104M
Q2 2023
$119M
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.